2013
DOI: 10.1111/aas.12051
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of oxycodone prolonged‐release vs. oxycodone + naloxone prolonged‐release after laparoscopic hysterectomy

Abstract: Addition of naloxone to oxycodone PR tablets in a pain regimen administered twice daily the first three post-operative days had no significant clinical effects on constipation or other variables during the first week after hysterectomy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 21 publications
0
17
0
Order By: Relevance
“…The study by Comelon and co-workers [13] on bowel functions after laparoscopic hysterectomies did not find effects on postoperative bowel function when comparing OxyContin ® 10 mg without naloxone with OxyContin ® 10 mg with 5 mg naloxone added (= Targin ® , Targiniq ® , Targinact ® ) twice daily. The amount of rescue oxycodone needed was considerable, thus it appears that the dose of prolonged release oxycodone was too low for pain relief [13]. In addition, it follows that the 10 mg of naloxone daily was too low to antagonize the bowel dysfunction caused by the total dose of oxycodone given after that operation.…”
Section: Oral Prolonged Release Naloxonementioning
confidence: 92%
See 2 more Smart Citations
“…The study by Comelon and co-workers [13] on bowel functions after laparoscopic hysterectomies did not find effects on postoperative bowel function when comparing OxyContin ® 10 mg without naloxone with OxyContin ® 10 mg with 5 mg naloxone added (= Targin ® , Targiniq ® , Targinact ® ) twice daily. The amount of rescue oxycodone needed was considerable, thus it appears that the dose of prolonged release oxycodone was too low for pain relief [13]. In addition, it follows that the 10 mg of naloxone daily was too low to antagonize the bowel dysfunction caused by the total dose of oxycodone given after that operation.…”
Section: Oral Prolonged Release Naloxonementioning
confidence: 92%
“…Moreover, for acute opioid-induced constipation in opioid naive patients a larger dose of a peripherally acting opioid antagonist is needed, compared with in patients on long-term opioid treatment for chronic pain conditions [10]. It is reasonable to expect the same is true for the prolonged release naloxone in the Targin ® , and that the dose of 10 mg of naloxone, also for this reason, was too small in their study [13].…”
Section: Oral Prolonged Release Naloxonementioning
confidence: 97%
See 1 more Smart Citation
“…However, they used oxycodone as a first line analgesic treatment, and no regional technique was used with the exception of bupivacaine injection at the incision sites. [12] An explanation why prolonged-release oxycodone failed to reduce the duration of TEA could be the specific pharmacokinetic conditions related to the early postoperative setting of a small bowel resection and anastomosis.…”
Section: A C C E P T E Dmentioning
confidence: 99%
“…Three published studies have addressed use of OXN for postoperative pain following orthopedic, gynecological, and cardiac surgery, with mixed results [63, 71, 72]. Improvement in bowel function has not been unequivocally demonstrated, potentially complicated by the low doses and brief treatment courses used and impact of gastrointestinal surgery on bowel function; analgesia was similar to intravenous (IV) opioids [63, 71, 72]. OXN is not recommended before surgery or for 12 to 24 h in the immediate postoperative period [46].…”
Section: Oxycodone/naloxone Sustained Release Formulationsmentioning
confidence: 99%